Robert Bain Thomas, Director at REVA Medical, Inc. (RVA), bought 2,500 shares at $7.80 ($19K) on 2016-06-17, disclosed to the SEC on 2016-06-21.
Open-market purchase of $19k RVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.78 | 201 | $2K | 8.0% |
| 2 | $7.80 | 2,299 | $18K | 92.0% |
| Total | $7.80 avg | 2,500 | $19K | 100% |
| Filing → |
| RVA.AX | BUY | 2018-06-01 | $10K | — | Filing → |
| RVA.AX | BUY | 2018-03-30 | $15K | — | Filing → |
| RVA.AX | BUY | 2018-03-28 | $15K | — | Filing → |